Livongo Health, a digital health startup focused on managing chronic conditions like diabetes and hypertension, raised $105 million in VC funding co-led by return backers General Catalyst and Kinnevik.
Why it's a big deal: Because it's big-money validation that the future of chronic disease monitoring will be done via connected mobile devices.
Cap table: Echo Health Ventures was the only new money, while other insiders included DFJ, Kleiner Perkins, Merck, Microsoft Ventures, Sapphire Ventures, 7wire Ventures and Zaffre Investments.
Bottom line: "Diabetes [is seen] as a significant driver of premium increases with more than 30 million Americans, or 9% of the U.S. population, suffering from diabetes, according to the American Diabetes Association. Another estimated 30 million Americans have diabetes but have yet to have it diagnosed, ADA statistics show." — Bruce Japsen, Forbes
